Comparative validity of inventories and checklists for identifying depressed patients with hidden bipolarity

Neuropsychiatry

Volumn 3, Issue 3, 2013, Pages 331-343

  Bech, Per ^a   Engell, Rikke ^a   Møller, Stine Bjerrum ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; MOOD STABILIZER; PLACEBO;

BECK DEPRESSION INVENTORY; BIPOLAR DEPRESSION; CHECKLIST; COMPARATIVE VALIDITY; DEPRESSION; DISEASE CLASSIFICATION; DRUG RESPONSE; DSM-5; DSM-IV; HUMAN; HYPOMANIA; HYPOMANIA CHECKLIST 32; MAJOR DEPRESSION; MENTAL PATIENT; MOOD DISORDER QUESTIONNAIRE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEWCASTLE DIAGNOSTIC DEPRESSION SCALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; VALIDITY;

EID: 84879346226     PISSN: 17582008     EISSN: 17582016     Source Type: Journal    
DOI: 10.2217/npy.13.28     Document Type: Review

References (77)

1. Angst J. The bipolar spectrum. Br. J. Psychiatry 190(3), 189-191 (2007).
2. Sharma V, Khan M, Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis? J. Affect. Disord. 84(2-3), 251-257 (2005).
3. Angst J. Bipolar disorder-methodological problems and future perspectives. Dialogues Clin. Neurosci. 10(2), 129-139 (2008).
4. Bech P. Clinical Psychometrics. John Wiley & Sons, Inc., NJ, USA (2012).
5. Tomba E, Bech P. Clinimetrics and clinical psychometrics: macro-and microanalysis. Psychother. Psychosom. 81(6), 333-343 (2012).
6. Perris C. A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Introduction. Acta Psychiatr. Scand. Suppl. 194, 9-14 (1966).
7. Angst J. Etiology and Nosology in Endogenous Depressive Psychosis. Springer, Berlin, Germany (1966).
8. Angst J, Perris C. On the nosology of endogenous depression. Comparison of the results of two studies. Arch. Psychiatr Nervenkr. 210(4), 373-386 (1968).
9. WHO. International Classifcation of Diseases: Ninth Revision (ICD-9). World Health Organization, Geneva, Switzerland (1978).
10. WHO. International Statistical Classifcation of Diseases and Related Health Problems, 10th Revision (ICD-10). Diagnostic Criteria for Research. World Health Organization, Geneva, Switzerland (1993).
11. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III). American Psychiatric Association, DC, USA (1980).
12. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). American Psychiatric Association, DC, USA (1994).
13. Perris C. Bipolar-unipolar distinction. In: Handbook of Affective Disorders. Paykel ES (Ed.). Churchill Livingstone, Edinburgh, UK, 57-76 (1992).
14. Kraepelin E. Psychiatry (8th Edition, Volume 3). Barth, Leipzig, Germany (1913).
15. Bech P. Clinical features of mood disorders and mania. In: New Oxford Textbook of Psychiatry. Gelder MG, Lopez-Ibor JJ, Andreasen N, Geddes J (Eds.). Oxford University Press, Oxford, UK (2009).
16. Citalopram: clinical effect profle in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group. Psychopharmacology (Berl.) 90(1), 131-138 (1986).
17. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. J. Affect. Disord. 18(4), 289-299 (1990).
18. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. J. Affect. Disord. 28, 105-116 (1993).
19. Bech P. Rating SCALES for Psychopathology, Health Status and Quality of Life. A Compendium on Documentation in Accordance with the DSM-III-R and WHO Systems. Springer, Berlin, Germany (1993).
20. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W. Toward a re-defnition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J. Affect. Disord. 73(1-2), 133-146 (2003).
21. Benazzi F. Frequency of bipolar spectrum in 111 private practice depression outpatients. Eur. Arch. Psychiatry Clin. Neurosci. 253(4), 203-208 (2003).
22. Angst J. Commentary on the paper of Smith et al. J. Psychopharmacol. 22(4), 404-405 (2008).
23. Fava GA. Clinical judgment in psychiatry. Requiem or reveille? Nord J. Psychiatry 67(1), 1-10 (2012).
24. Hantouche EG, Angst J, Akiskal HS. Factor structure of hypomania: interrelationships with cyclothymia and the soft bipolar spectrum. J. Affect. Disord. 73(1-2), 39-47 (2003).
25. Hantouche EG, Angst J. National bipolarity survey. In search of hypomania in diffcult-to-treat depression. Bipolact 1, 4-12 (2007).
26. Zimmermann P, Bruckl T, Nocon A et al. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity Arch. Gen. Psychiatry 66(12), 1341-1352 (2009).
27. Angst J, Cui L, Swendsen J et al. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am. J. Psychiatry 167(10), 1194-1201 (2010).
28. Goodwin GM, Anderson I, Arango C et al. ECNP consensus meeting. Bipolar depression. Nice, March 2007 Eur. Neuropsychopharmacol. 18(7), 535-549 (2008).
29. Eckblad M, Chapman LJ. Development and validation of a scale for hypomanic personality. J. Abnorm. Psychol. 95(3), 214-222 (1986).
30. Kwapil TR, Miller MB, Zinser MC, Chapman LJ, Chapman J, Eckblad M. A longitudinal study of high scorers on the hypomanic personality scale. J. Abnorm. Psychol. 109(2), 222-226 (2000).
31. Meads DM, Bentall RP. Rasch analysis and item reduction of the hypomanic personality scale. Pers. Individ. Dif. 44(8), 1772-1783 (2008).
32. Angst J, Adolfsson R, Benazzi F et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J. Affect. Disord. 88(2), 217-233 (2005).
33. Hirschfeld RM, Williams JB, Spitzer RL et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am. J. Psychiatry 157(11), 1873-1875 (2000).
34. Ghaemi NS, Miller CJ, Berv DA, Klugman J, Rosenquist KJ, Pies RW. Sensitivity and specifcity of a new bipolar spectrum diagnostic scale. J. Affect. Disord. 84(2-3), 273-277 (2005).
35. Zimmerman M, Galione JN, Chelminski I, Young D, Ruggero CJ. Performance of the Bipolar Spectrum Diagnostic Scale in psychiatric outpatients. Bipolar Disord. 12(5), 528-538 (2010).
36. Eysenck HJ, Eysenck SBG. Personality Structure and Measurement. Routledge and Kegan Paul, London, UK (1969).
37. Leao IAT, Del Porto JA. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Brazil: the 32 item hypomania symptom check-list, frst revision (HCI-32-R1). J. Affect. Disord. 140(3), 215-221 (2012).
38. Spearman C. The proof and measurement of association between two things. Amer. J. Psychol. 15, 72-101 (1904).
39. Guilford JP. Psychometric Methods. McGraw-Hill, NY, USA (1954).
40. Cattell RB. The Scientifc Use of Factor Analysis. Plenum Press, NY, USA (1978).
41. An D, Hong KS, Kim JH. Exploratory factor analysis and confrmatory factor analysis of the korean version of Hypomania Checklist-32. Psychiatry Investig. 8(4), 334-339 (2011).
42. Soares OT, Moreno DH, Moura EC, Angst J, Moreno RA. Reliability and validity of a Brazilian version of the Hypomania Checklist (HCL-32) compared to the Mood Disorder Questionnaire (MDQ). Rev. Bras. Psiquiatr. 32(4), 416-423 (2010).
43. Child D. The Essentials of Factor Analysis (3rd Edition). Continuum, London, UK (2006).
44. Rybakowski JK, Angst J, Dudek D et al. Polish version of the Hypomania Checklist (HCL-32) scale: the results in treatment-resistant depression. Eur. Arch. Psychiatry Clin. Neurosci. 260(2), 139-144 (2010).
45. Bech P, Christensen EM, Vinberg M, Bech-Andersen G, Kessing LV. From items to syndromes in the Hypomania Checklist (HCL-32): psychometric validation and clinical validity analysis. J. Affect. Disord. 132(1-2), 48-54 (2011).
46. L Baer, Blais MA. Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. Human Press, NY, USA (2010).
47. Calabrese JR, Muzina DJ, Kemp DE et al. Predictors of bipolar disorder risk among patients currently treated for major depression. MedGenMed 8(3), 38 (2006).
48. Dudek D, Rybakowski JK, Siwek M et al. Risk factors of treatment resistance in major depression: association with bipolarity. J. Affect. Disord. 126(1-2), 268-271 (2010).
49. Rybakowski JK, Dudek D, Pawlowski T, Lojko D, Siwek M, Kiejna A. Use of the hypomania checklist-32 and the mood disorder questionnaire for detecting bipolarity in 1051 patients with major depressive disorder. Eur. Psychiatry 27(8), 577-581 (2012).
50. Price LH, Carpenter LL, Rasmussen SA. Drug combination strategies. In: Treatment-Resistant Mood Disorders. Amsterdam JD, Harning M, Neirenberg AA (Eds.). Cambridge University Press, Cambridge, USA, 194-222 (2001).
51. Licht RW, Vestergaard P, Brodersen A. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up. Bipolar Disord. 10(1), 79-86 (2008).
52. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4, 561-571 (1961).
53. Kendell RE. The Role of Diagnosis in Psychiatry. Wiley-Blackwell, Oxford, UK (1975).
54. Parker G, Manicavasagar V. Modelling and Managing the Depressive Disorders. Cambridge University Press, Cambridge, UK (2005).
55. Parker G. Diagnosis, Classifcation, and differential diagnosis of the mood disorders. In: New Oxford Textbook of Psychiatry. Gelder MG, Andreason NC, Lopez-Ibor JJ, Geddes J (Eds.). Oxford University Press, Oxford, UK, 637-644 (2009).
56. Perlis RH, S moller JW, Fava M, Rosenbaum JF, Nierenberg AA, Sachs GS. The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder. J. Affect. Disord. 79(1-3), 291-295 (2004).
57. Kraepelin E. Manic-Depressive Insanity and Paranoia. Livingstone, Edinburgh, UK (1921).
58. Dein E. On the concept of autism. Acta Psychiatr. Scand. 191, 124-135 (1966).
59. Bech P. Autism as the clinical core marker in schizophrenia. World Psychiatry 12(1), 81 (2013).
60. Kendell RE, DiScipio WJ. Eysenck personality inventory scores of patients with depressive illnesses. Br. J. Psychiatry 114(511), 767-770 (1968).
61. Bech P, Lunde M, Møller SB. Eysenck's two big personality factors and their relationship to depression in patients with chronic idiopathic pain disorder: a clinimetric validation analysis. ISRN Psychiatry 2012, 140458 (2012).
62. Mansell W, Morrison AP. The interpretation of, and responses to, changes in internal states: an integrative cognitive model of mood swings and bipolar disorders. Behav. Cogn. Psychother. 35, 515-539 (2007).
63. Meyer B, Johnson SL, Carver CS. Exploring behavioral activation and inhibition sensitivities among college students at risk for bipolar spectrum symptomatology. J. Psychopathol. Behav. Assess. 21(4), 275-292 (1999).
64. Eysenck HJ, Eysenck SPB. Manual of the Eysenck Personality Questionnaire. Hodder Stoughton, London, UK (1975).
65. Carta MG, Hardoy MC, Cadeddu M et al. The accuracy of the Italian version of the Hypomania Checklist (HCL-32) for the screening of bipolar disorders and comparison with the Mood Disorder Questionnaire (MDQ) in a clinical sample. Clin. Pract. Epidemiol. Ment. Health. 2, 2 (2006).
66. Chou CC, Lee IH, Yeh TL et al. Comparison of the validity of the Chinese versions of the Hypomania Symptom Checklist-32 (HCL-32) and Mood Disorder Questionnaire (MDQ) for the detection of bipolar disorder in medicated patients with major depressive disorder. Int. J. Psychiatry Clin. Pract. 16(2), 132-137 (2012).
67. Forty L, Smith D, Jones L et al. Identifying hypomanic features in major depressive disorder using the hypomania checklist (HCL-32). J. Affect. Disord. 114(1-3), 68-73 (2009).
68. Forty L, Kelly M, Jones L et al. Reducing the Hypomania Checklist (HCL-32) to a 16-item version. J. Affect. Disord. 124(3), 351-356 (2010).
69. Leao IAT, Del Porto JA. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Brazil: the 32 item hypomania symptom check-list, frst revision (HCI-32-R1). J. Affect. Disord. 140 (3), 215-221 (2012).
70. Meyer TD, Bernhard B, Born C et al. The Hypomania Checklist-32 and the Mood Disorder Questionnaire as screening tools-going beyond samples of purely mood-disordered patients. J. Affect. Disord. 128(3), 291-298 (2011).
71. Perugi G, Fornaro M, Maremmani I et al. Discriminative hypomania checklist-32 factors in unipolar and bipolar major depressive patients. Psychopathology 45(6), 390-398 (2012).
72. Poon Y, Chung KF, Tso KC, Chang CL, Tang D. The use of Mood Disorder Questionnaire, Hypomania Checklist-32 and clinical predictors for screening previously unrecognised bipolar disorder in a general psychiatric setting. Psychiatry Res. 195(3), 111-117 (2012).
73. Rybakowski JK. Bipolarity and inadequate response to antidepressant drugs: clinical and psychopharmacological perspective. J. Affect. Disord. 136(1-2), e13-e19 (2012).
74. Smith DJ, Griffths E, Kelly M, Hood K, Craddock N, Simpson SA. Unrecognised bipolar disorder in primary care patients with depression. Br. J. Psychiatry 199(1), 49-56 (2011).
75. Wu YS, Angst J, Ou CS, Chen HC, Lu RB. Validation of the Chinese version of the hypomania checklist (HCL-32) as an instrument for detecting hypo(mania) in patients with mood disorders. J. Affect. Disord. 106(1-2), 133-143 (2008).
76. Yang HC, Xiang YT, Liu TB et al. Hypomanic symptoms assessed by the HCL-32 in patients with major depressive disorder: a multicenter trial across China. J. Affect. Disord. 143(1-3), 203-207 (2012).
77. Yang HC, Yuan CM, Liu TB et al. Validit y of the 32-item Hypomania Checklist (HCL-32) in a clinical sample with mood disorders in China. BMC Psychiatry 11, 84 (2011).